Docstoc

Pomerantz Law Firm Investigates Claims on Behalf of Investors of Ardea Biosciences, Inc

Document Sample
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Ardea Biosciences, Inc Powered By Docstoc
					
				
DOCUMENT INFO
Shared By:
Tags:
Stats:
views:0
posted:4/23/2012
language:
pages:1
Description: NEW YORK--(EON: Enhanced Online News)--Pomerantz Haudek Grossman & Gross LLP is investigating claims on behalf of investors of Ardea Biosciences, Inc. (“Ardea” or the “Company”) (NASDAQ:RDEA) (ISIN: US03969P1075) concerning the proposed acquisition of Ardea by AstraZeneca in a cash transaction valued at approximately $1.26 billion. The investigation concerns whether Ardea directors are breaching their fiduciary duties by failing to adequately shop the Company and maximize shareholder value. a style='font-size: 1
EON: Enhanced Online News EON: Enhanced Online News http://eon.businesswire.com
About At EON: Enhanced Online News, we show you how to make your online press release thrive. If you want to drive traffic to your website, generate sales leads, make an announcement, or promote a new product, EON: Enhanced Online News delivers the online visibility that you need. EON: Enhanced Online News powered by Business Wire.